Abstract:The aim of this study was to develop esomeprazole magnesium (EMZ-Mg) enteric-coated pellets and pellet-based tablets, as well as to investigate the effects of pellet size and compression method on acid tolerance, content uniformity, compressibility, and stability of preparations. This study used two types of pellet cores, namely, microcrystalline cellulose (MCC) core with a particle size of 150–300 μm and sucrose core with a particle size of 600–700 μm. Enteric-coated pellets, which consisted of a drug-free core, a drug layer, a sub-coating layer (hydroxypropyl methylcellulose, 6 cps), and an enteric-coating layer (Eudragit®L30D-55), were prepared by using a bottom-spray fluidized bed-coating technique. Pellet-based tablets were prepared by using a direct compression method or a wet granulation method. The acid tolerances of the two types of enteric-coated pellets (MCC and sucrose cores) reached up to 98% in simulated gastric fluid (pH 1.0) within 2 h, and the dissolution rates in simulated intestinal fluid (pH 6.8) reached up to 85% of the labeled amount within 15 min. When compressed into tablets, the pellets based on MCC core (smaller particle size) displayed a significantly higher acid tolerance (up to 92%) compared with the pellets based on sucrose core (larger particle size). In addition, the MCC core-based tablets (F8), especially those prepared by using a granulation method, showed higher drug content uniformity and compressibility than the sucrose core-based tablets (F10), and no lamination phenomenon was observed during compression. The crystallinity of EMZ-Mg was altered during drug layering process, and some physicochemical interactions were observed between the drug and excipients. Moreover, the two types of enteric-coated pellets showed a relatively high stability after storage under high temperature and strong light. However, they showed poor stability under high humidity, resulting in remarkable degradation of active compound. The EMZ-Mg enteric-coated pellets and pellet-based tablets were successfully developed, and reduction in pellet size and wet granulation reduced the differences in content uniformity and better protected the pellet coating from damages during compression.

Preparation and in Vitro/in Vivo Evaluation of Esomeprazole Magnesium-Modified Release Pellets.

Esomeprazole Magnesium Enteric-Coated Pellet-Based Tablets with High Acid Tolerance and Good Compressibility

Novel Naproxen/esomeprazole Magnesium Compound Pellets Based on Acid-Independent Mechanism:In Vitroandin Vivoevaluation

Novel Naproxen/esomeprazole Magnesium Compound Pellets Based on Acid-Independent Mechanism: in Vitro and in Vivo Evaluation.

Study on pramipexole dihydrochloride sustained-release tablets

Preparation and Evaluation of Dual–release Esomeprazole Magnesium Pulsed Capsules Filled with Two Kinds of Enteric-coated Pellets

Preparation of esomeprazole magnesium enteric-coated pellets by extrusion spheronization

Novel Esomeprazole Magnesium-Loaded Dual-Release Mini-Tablet Polycap: Formulation, Optimization, Characterization, and In Vivo Evaluation in Beagle Dogs

Preparation of Esomeprazole Zinc Solid Dispersion and Study on Its Pharmacokinetics

Preparation of Omeprazole Gastric Immediate Release Tablets and Study on the Formulation Thereof

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

Development and In vitro and In vivo Evaluations of a Microemulsion Formulation for the Oral Delivery of Oxaprozin

Preparation and Dissolution in Vitro of Esomeprazole Zinc Solid Dispersion

A novel pulsatile drug delivery system based on the physiochemical reaction between acrylic copolymer and organic acid: In vitro and in vivo evaluation

Bridging the structure gap between pellets in artificial dissolution media and in gastro-intestinal tract in rats

Preparation and in vitro Release of Doxazosin Mesylate Controlled-Release Tablets

Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization

Bridging the structure gap between pellets in artificial dissolution media and in gastrointestinal tract in rats

[Preparation of Pantoprazole Sodium Enteric-Coated Pellets-Type Tablets].

Novel Application Method of Talcum Powder to Prevent Sticking Tendency and Modify Release of Esomeprazole Magnesium Enteric-Coated Pellets